Insufficient Plasma Melatonin and Its Association With Neuropsychiatric Impairments in Patients With T2DM
Conclusion: MLT levels decreased in patients with T2DM and were associated with neuropsychiatric impairments and inflammatory status, and MLT might be developed as a therapeutic agent and predictive indicator for T2DM-associated executive impairment and depression status.
Uloženo v:
| Hlavní autoři: | , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Wiley
2024-01-01
|
| Edice: | Journal of Diabetes Research |
| On-line přístup: | http://dx.doi.org/10.1155/2024/5661751 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
